We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Gait Disturbances and Hips Bone Mineral Density

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01554605
Recruitment Status : Unknown
Verified March 2012 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : March 15, 2012
Last Update Posted : March 15, 2012
Information provided by (Responsible Party):
Tel-Aviv Sourasky Medical Center

Brief Summary:
The objective of this study is to investigate the role of gait disturbance as a cause for difference in Bone Mineral Density (BMD) between both hips. Each subject will undergo the following tests: Functional Mobility Testing, Gait analysis, Motion Analysis, Assessments for Balance and Gait and Cognitive assessments.

Condition or disease
Difference in BMD Between Both Hips

Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Case-Crossover
Time Perspective: Prospective
Study Start Date : March 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Minerals
U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   40 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
subjects will be recruited from the bone clinic

Inclusion Criteria:

  1. differeneces in hips in Bone Mineral Density test in one group.
  2. Age 40-80.

Exclusion Criteria:

  1. bone disease,
  2. arthritis,
  3. congenital skeletal malformations,
  4. pregnancy,
  5. neurological disease

Responsible Party: Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier: NCT01554605     History of Changes
Other Study ID Numbers: TASMC-12-NV-648-CTIL
First Posted: March 15, 2012    Key Record Dates
Last Update Posted: March 15, 2012
Last Verified: March 2012